What is your preferred PMRT dose/fractionation for patients with implant reconstruction?

I stated in a post in July 2022, that I switched to using hypofractionation for patients with both autologous and implant-based reconstructions after the FABREC trial closed, which we participated in. The results of FABREC presented at ASTRO showed no significant difference between the hypofractiona...